OPTIMIZING EPO THERAPY WITH LOW-DOSE IV IRON ADMINISTRATION IN HEMODIALYSIS (HD) PATIENTS

被引:0
|
作者
SUNDERPLASSMANN, G [1 ]
HORL, WH [1 ]
机构
[1] UNIV VIENNA, INNERE MED KLIN 3, VIENNA, AUSTRIA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:998 / 998
页数:1
相关论文
共 50 条
  • [21] Assessment of a response to IV iron (Fe) in hemodialysis patients receiving recombinant erythropoietin (EPO)
    Seligman, PA
    Schleicher, R
    Shapiro, JR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1075 - A1075
  • [22] PREVENTION OF THROMBOSIS BY LOW-DOSE ASPIRIN IN PATIENTS ON HEMODIALYSIS
    FRIEDMAN, EA
    NEW ENGLAND JOURNAL OF MEDICINE, 1980, 302 (03): : 179 - 179
  • [23] Hemoglobin Control, ESA Resistance, and Regular Low-Dose IV Iron Therapy: A Review of the Evidence
    Singh, Ajay
    SEMINARS IN DIALYSIS, 2009, 22 (01) : 64 - 69
  • [24] PREVENTION OF THROMBOSIS IN PATIENTS ON HEMODIALYSIS BY LOW-DOSE ASPIRIN
    HARTER, HR
    BURCH, JW
    MAJERUS, PW
    STANFORD, N
    DELMEZ, JA
    ANDERSON, CB
    WEERTS, CA
    NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (11): : 577 - 579
  • [25] URINARY ACIDIFICATION RESPONSE TO FUROSEMIDE ADMINISTRATION IN PATIENTS ON LOW-DOSE CYCLOSPORINE THERAPY
    QUEREDA, C
    SORIA, C
    GALLEGO, N
    SABATER, J
    PASCUAL, J
    OROFINO, L
    ORTUNO, J
    AMERICAN JOURNAL OF NEPHROLOGY, 1993, 13 (02) : 107 - 114
  • [26] Subcutaneous (SQ) erythropoietin (EPO) in hemodialysis (HD) patients.
    Zacherle, BJ
    Nakayama, B
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1278 - A1278
  • [27] Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis
    Pu, Tao
    Ni, Yu
    Li, Pan-hong
    Yu, Dan
    Yu, Qiong
    Yu, Li-mei
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2022, 363 (02): : 185 - 190
  • [28] LOW-DOSE INTRAVENOUS CALCITRIOL-BOLUS THERAPY IN CHRONIC-HEMODIALYSIS PATIENTS
    NEYER, U
    WOSS, E
    DREXEL, H
    ACTA MEDICA AUSTRIACA, 1994, 21 (05) : 129 - 132
  • [29] Long-Term Low-Dose Spironolactone Therapy Is Safe in Oligoanuric Hemodialysis Patients
    Matsumoto, Yoshihiro
    Kageyama, Shinji
    Yakushigawa, Toru
    Arihara, Kazuo
    Sugiyama, Toshikazu
    Mori, Yasuo
    Sugiyama, Hatsumi
    Ohmura, Hiromichi
    Shio, Nobuo
    CARDIOLOGY, 2009, 114 (01) : 32 - 38
  • [30] LOW-DOSE RECOMBINANT-HUMAN-ERYTHROPOIETIN THERAPY IN CHRONIC-HEMODIALYSIS PATIENTS
    DUFF, DR
    GOLPER, TA
    SLOAN, RS
    BRIER, ME
    ARONOFF, GR
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 18 (01) : 60 - 64